Sun Y. Kim

Sun Y. Kim

Auto-generated profile, based on publicly available information

Sun Y. Kim

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Noura Abul-HusnNoura Abul-Husn
Noura Abul-Husn
XCXiping Cheng
Xiping Cheng
ALAlexander H. Li
Alexander H. Li
YXYurong Xin
Yurong Xin
CSClaudia Schurmann
Claudia Schurmann
FDFrederick E. Dewey
Frederick E. Dewey
Elucidation of the genetic factors underlying chronic liver disease may reveal new therapeutic targets. We used exome sequence data and electronic health records from 46,544 participants in the DiscovEHR human genetics study to identify genetic variants associated with serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for association with clinical diagnoses of chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples. A splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was found to be associated with reduced levels of ALT (P=4.2×10−12) and AST (P=6.2×10−10). Among DiscovEHR study participants, this variant was found to be associated with a reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes), and nonalcoholic cirrhosis (by 26% [95% CI, 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA variant was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity. A loss-of-function variant in HSD17B13 is associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)

7 February 2018 in Nature
Verified
Journal Article
Closed access
PDF file
SKSimon R. V. Knott
Simon R. V. Knott
EWElvin Wagenblast
Elvin Wagenblast
SKShowkhin Khan
Showkhin Khan
SKSun Y. Kim
Sun Y. Kim
MSMar Soto
Mar Soto
GHGregory J. Hannon
Gregory J. Hannon

8 April 2015 in Nature
Verified
Journal Article
Closed access
PDF file
EWElvin Wagenblast
Elvin Wagenblast
MSMar Soto
Mar Soto
SGSara Gutiérrez-Ángel
Sara Gutiérrez-Ángel
CHChristina A. Hartl
Christina A. Hartl
AGAnnika L. Gable
Annika L. Gable
SKSimon R. V. Knott
Simon R. V. Knott

6 October 2021 in iScience
Verified
Journal Article
Open access
QSQi Su
Qi Su
SKSun Y. Kim
Sun Y. Kim
FAFunmi Adewale
Funmi Adewale
YZYe Zhou
Ye Zhou
CAChristina Aldler
Christina Aldler
XCXiping Cheng
Xiping Cheng
Nonalcoholic fatty liver disease (NAFLD) is a global health-care problem with limited therapeutic options. To obtain a cellular resolution of pathogenesis, 82,168 single-cell transcriptomes (scRNA-seq) across different NAFLD stages were profiled, identifying hepatocytes and 12 other non-parenchymal cell (NPC) types. scRNA-seq revealed insights into the cellular and molecular mechanisms of the disease. We discovered a dual role for hepatic stellate cells in gene expression regulation and in the potential to trans-differentiate into myofibroblasts. We uncovered distinct expression profiles of Kupffer cells versus monocyte-derived macrophages during NAFLD progression. Kupffer cells showed stronger immune responses, while monocyte-derived macrophages demonstrated a capability for differentiation. Three chimeric NPCs were identified including endothelial-chimeric stellate cells, hepatocyte-chimeric endothelial cells, and endothelial-chimeric Kupffer cells. Our work identified unanticipated aspects of mouse with NAFLD at the single-cell level and advanced the understanding of cellular heterogeneity in NAFLD livers.

1 December 2014 in Molecular Cell
Verified
Journal Article
Closed access
SKSimon R.V. Knott
Simon R.V. Knott
AMAshley R. Maceli
Ashley R. Maceli
NENicolas Erard
Nicolas Erard
KCKenneth Chang
Kenneth Chang
KMKrista Marran
Krista Marran
GHGregory J. Hannon
Gregory J. Hannon

19 March 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
XCXiping Cheng
Xiping Cheng
SKSun Y. Kim
Sun Y. Kim
HOHaruka Okamoto
Haruka Okamoto
YXYurong Xin
Yurong Xin
GYGeorge D. Yancopoulos
George D. Yancopoulos
JGJesper Gromada
Jesper Gromada
Significance: The lobules are the functional units of the liver. They consist of 15–25 layers of hepatocytes with specialized metabolic functions and gene expression patterns relative to their position along the lobule, a phenomenon referred to as metabolic zonation. The Wnt/β-catenin pathway regulates hepatocyte function but how the zonation is controlled to meet the metabolic demands of the liver is unclear. Glucagon regulates hepatic function. We now demonstrate that glucagon contributes to liver zonation by interacting and opposing the actions of the Wnt/β-catenin pathway.